US Patent Issued to Charles River Laboratories on Feb. 3 for "Recombinant amebocyte clotting factors and uses thereof" (New York, South Carolina Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,944, issued on Feb. 3, was assigned to Charles River Laboratories Inc. (Wilmington, Mass.).

"Recombinant amebocyte clotting factors and uses thereof" was invented by Masakazu Tsuchiya (Mount Pleasant, S.C.) and Norman R. Wainwright (Skaneateles, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are recombinant amebocyte clotting factors, their formulation and use in determining the presence and/or amount of a microbial endotoxin in a sample. Also provided is a cartridge containing the recombinant amebocyte clotting factors for determining the presence and/or amount of a microbial endotoxin in a sample."

The patent was filed on Nov. 20, 20...